Search
Descriptor English: Sympatholytics
Descriptor Spanish: Simpaticolíticos
Descriptor simpaticolíticos
Entry term(s) agente simpaticolítico
agentes simpaticolíticos
bloqueadores simpáticos
bloqueantes simpáticos
efecto simpaticolítico
efectos simpaticolíticos
fármaco simpaticolítico
fármacos simpaticolíticos
simpaticolítico
Scope note: Fármacos que inhiben las acciones del sistema nervioso simpático por cualquier mecanismo. Entre los más comunes se encuentran los ANTAGONISTAS ADRENÉRGICOS y fármacos que producen depleción de noradrenalina o reducen la liberación de transmisores desde las terminales posganglionares adrenérgicas (ver AGENTES ADRENÉRGICOS). Se incluyen en esta categoría los fármacos que actúan en el sistema nervioso central para reducir la actividad simpática (por ejemplo, agonistas adrenérgicos alfa-2 de acción central, ver AGONISTAS ADRENÉRGICOS ALFA).
Descriptor Portuguese: Simpatolíticos
Descriptor French: Sympatholytiques
Entry term(s): Agents, Sympathetic-Blocking
Agents, Sympatholytic
Drugs, Sympatholytic
Effect, Sympatholytic
Effects, Sympatholytic
Sympathetic Blocking Agents
Sympathetic-Blocking Agents
Sympatholytic
Sympatholytic Agent
Sympatholytic Agents
Sympatholytic Drug
Sympatholytic Drugs
Sympatholytic Effect
Sympatholytic Effects
Tree number(s): D27.505.696.663.050.850
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D013565
Scope note: Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
Annotation: note entry term SYMPATHOLYTIC EFFECT: use only for the sympatholytic effect of a chemical substance
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Public MeSH Note: ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Online Note: use SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81
History Note: ADRENERGIC FALSE TRANSMITTERS was heading 1973-81
Related: Adrenergic Agents MeSH
Adrenergic Antagonists MeSH
DeCS ID: 13945
Unique ID: D013565
NLM Classification: QV 132
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1960/01/01
Date of Entry: 1999/01/01
Revision Date: 2011/06/24
Sympatholytics - Preferred
Concept UI M0020945
Scope note Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
Preferred term Sympatholytics
Entry term(s) Agents, Sympathetic-Blocking
Agents, Sympatholytic
Drugs, Sympatholytic
Sympathetic Blocking Agents
Sympathetic-Blocking Agents
Sympatholytic
Sympatholytic Agent
Sympatholytic Agents
Sympatholytic Drug
Sympatholytic Drugs
Sympatholytic Effect - Related but not broader or narrower
Concept UI M0556220
Preferred term Sympatholytic Effect
Entry term(s) Effect, Sympatholytic
Effects, Sympatholytic
Sympatholytic Effects



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey